2019 annual financial data
Cardiff Oncology 2019 Operating margin
Direct answer
Operating margin was -6,817.79%.
Operating income was -16,678,494 USD and net income was -16,414,159 USD.
Operating cash flow was -13,268,000 USD.
Get free Cardiff Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 244,632 USD
- Operating income
- -16,678,494 USD
- Net income
- -16,414,159 USD
- Operating cash flow
- -13,268,000 USD